The Covid Consortium

The COVID Consortium brings the critical and necessary resources of multiple CLIA certified, CAP and COLA accredited medium and high complexity laboratories, clinicians and technology together to allow the delivery of a consistent COVID-19 test with equally consistent result delivery.


Who We Are

In Mid March, as the COVID-19 crisis continued in the U.S., one thing became clear to the medical staff at CopernicusMD; either States didn’t desire mass testing for COVID-19 infection or, they simply couldn’t organize it. 

It was puzzling to think that with the resources of the Federal and State governments on both an academic and financial level that broad-based testing in every state could not be mobilized.  So the Medical team at CopernicusMD got to work.


The mission of the COVID Consortium has two critical priority points.

We recognize the need for reliable, clinically valid testing at scale.

We recognize the need for broad based COVID-19 testing at the employer level to support the re-opening of the American economy.

Latest in the News

Get the latest news for your business from the experts.

  • Cases in the U.S.
    on May 24, 2022 at 5:09 pm

    CDC COVID Data Tracker - Cases and Deaths by State

  • Selected Adverse Events Reported after COVID-19 Vaccination
    on May 24, 2022 at 4:00 am

    COVID-19 vaccines are safe and effective. Millions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history. CDC recommends you get a COVID-19 vaccine as soon as you are eligible. Adverse events described on this page have been reported to the Vaccine Adverse Event Reporting System (VAERS).

  • COVID-19 Vaccine Booster Shot
    on May 24, 2022 at 4:00 am

    People who have had 2 shots of Pfizer-BioNTech or Moderna vaccines may need to start receiving a COVID-19 booster shot 8 months after their second dose.

  • Stay Up to Date with Your Vaccines
    on May 24, 2022 at 4:00 am

    people who are up to date with their vaccines are well protected from serious illness or other health outcomes.

  • Staffing Resources
    on May 24, 2022 at 4:00 am

    Federal staffing resources for health departments.

  • COVID-19 Vaccines for Moderately to Severely Immunocompromised People
    on May 24, 2022 at 4:00 am

    CDC recommends that moderately or severely immunocompromised people receive an additional dose of mRNA COVID-19 vaccine at least four weeks after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.